ZNTL Zentalis Pharmaceuticals, Inc.

NASDAQ
$3.83

Zentalis Pharmaceuticals, Inc. (ZNTL) SEC Filings

Everything ZNTL has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

2 filings
Date Form Filing
SCHEDULE 13G/A
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.